Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

2 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

4(44.4%)

Phase 3

2(22.2%)

Phase 1

2(22.2%)

Early Phase 1

1(11.1%)

9Total

N/A(4)

Phase 3(2)

Phase 1(2)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT04396899Phase 1Recruiting

Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure

Role: collaborator

NCT06626789Phase 1Recruiting

Brain Signal Training to Enhance Affect Down-regulation

Role: collaborator

NCT07079787Not ApplicableNot Yet Recruiting

Telerehabilitation Decision Support System: Pilot Testing Protocol

Role: collaborator

NCT06534164Not ApplicableNot Yet Recruiting

Telerehabilitation of Balance Clinical and Economic Decision Support System

Role: collaborator

NCT04342780Completed

Prevalence of Delayed Chemotherapy Associated Nausea

Role: collaborator

NCT04794764Not ApplicableCompleted

Videolaryngoscopy Compared to Direct Laryngoscopy

Role: collaborator

NCT05780216Early Phase 1Completed

Mindfulness and Psychedelics

Role: collaborator

NCT01603407Phase 3Completed

Finding the Optimum Regimen for Duchenne Muscular Dystrophy

Role: collaborator

NCT04018235Completed

Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast Cancer

Role: collaborator

NCT05346978Not ApplicableCompleted

Nasturtium (Tropaeolum Majus L) Intake and Biochemical Parameters in Pre-diabetic Subjects in Bogota Colombia

Role: collaborator

NCT04021823Unknown

Neurobiological Analyses Within the FORESEE III Study

Role: collaborator

NCT00655343Phase 3Completed

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

Role: collaborator

All 12 trials loaded